Cable Hill Partners’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2018
Q1
Sell
-400
Closed -$11K 971
2017
Q4
$11K Buy
+400
New +$11K ﹤0.01% 559